Kap inhibitors refer to a class of chemical compounds that interfere with the activity of the karyopherin (Kap) family of proteins, which are involved in the transport of molecules between the cytoplasm and the nucleus in eukaryotic cells. Karyopherins, which include importins and exportins, play an essential role in the nucleocytoplasmic transport of various macromolecules, including proteins and RNAs. These inhibitors act by blocking the interactions between karyopherins and their cargo molecules or by disrupting the karyopherins' ability to bind and translocate through the nuclear pore complex (NPC). This disruption of the Kap-dependent transport process can have significant effects on cellular function, including altering the localization and activity of transcription factors, signaling molecules, and other nuclear-cytoplasmic shuttling proteins.
The mechanism of action of Kap inhibitors typically involves binding to specific sites on the karyopherins or their cargo, preventing the formation of a stable complex required for transport across the nuclear envelope. Some inhibitors may also interfere with the Ran GTPase cycle, which is crucial for the directionality of nucleocytoplasmic transport. Kap inhibitors are valuable research tools for probing the dynamics of nuclear import and export, as well as for understanding the role of nucleocytoplasmic transport in regulating cellular responses to stress, gene expression, and signal transduction. By modulating these fundamental cellular processes, Kap inhibitors can provide insights into the regulation of nuclear-cytoplasmic partitioning and its impact on cellular homeostasis.
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Flutamide | 13311-84-7 | sc-204757 sc-204757A sc-204757D sc-204757B sc-204757C | 1 g 5 g 25 g 500 g 1 kg | $46.00 $153.00 $168.00 $515.00 $923.00 | 4 | |
An antiandrogen that can affect KAP expression by inhibiting androgen receptors, reducing androgen-mediated effects. | ||||||
Bicalutamide | 90357-06-5 | sc-202976 sc-202976A | 100 mg 500 mg | $41.00 $143.00 | 27 | |
This nonsteroidal antiandrogen may modulate KAP levels by blocking androgen receptors, impacting androgen-regulated processes. | ||||||
Finasteride | 98319-26-7 | sc-203954 | 50 mg | $103.00 | 3 | |
A 5α-reductase inhibitor that can influence KAP by reducing the conversion of testosterone to dihydrotestosterone. | ||||||
Dutasteride | 164656-23-9 | sc-207600 | 10 mg | $167.00 | 2 | |
Similar to Finasteride, this inhibitor of 5α-reductase could affect KAP expression by altering dihydrotestosterone levels. | ||||||
MDV3100 | 915087-33-1 | sc-364354 sc-364354A | 5 mg 50 mg | $240.00 $1030.00 | 7 | |
An androgen receptor antagonist that may indirectly modulate KAP expression by inhibiting androgenic signaling. | ||||||
Spironolactone | 52-01-7 | sc-204294 | 50 mg | $107.00 | 3 | |
As an aldosterone antagonist with antiandrogenic effects, it might influence KAP expression. | ||||||
Cyproterone Acetate | 427-51-0 | sc-204703 sc-204703A | 100 mg 250 mg | $60.00 $199.00 | 5 | |
A synthetic steroid with antiandrogen properties, potentially modulating KAP expression by affecting androgen signaling. | ||||||
Ketoconazole | 65277-42-1 | sc-200496 sc-200496A | 50 mg 500 mg | $62.00 $260.00 | 21 | |
An antifungal with antiandrogenic activity, which may affect KAP by inhibiting steroid synthesis, including androgens. | ||||||
Abiraterone Acetate | 154229-18-2 | sc-207240 | 5 mg | $231.00 | 1 | |
Used to reduce androgen production, it could modulate KAP expression by lowering androgen levels. | ||||||
Eplerenone | 107724-20-9 | sc-203943 sc-203943A | 10 mg 50 mg | $108.00 $612.00 | 4 | |
A selective aldosterone receptor antagonist, might have a secondary effect on androgen-regulated proteins like KAP. |